BONGERS, ANKE,KAMPHUIS, PATRICK JOSEPH GERARDUS HENDRIKUS,GROENENDIJK, MARTINE
申请号：
NZ59974808
公开号：
NZ599748A
申请日:
2008.06.20
申请国别(地区):
NZ
年份:
2013
代理人:
摘要：
599748 Discloses the use of Uridine or uridine phosphate and Docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) In the manufacture of a product for improving impaired delayed recall function, for the treatment and/or prevention of an impaired delayed recall function, or improving memory and/or treatment or prevention of impaired memory function in a subject with a mini-mental state examination of 24, 25 or 26, wherein said product is enterally administered to the subject.
